OsteoRemedies

Company overview

OsteoRemedies is a Memphis, Tennessee medical device company founded in 2013. It is part of Demetra Holding and focuses on revision surgery and orthopedic infection management.

Its core portfolio comprises REMEDY hip, knee and shoulder spacers and SPECTRUM GV antibiotic bone cement. The wider catalog includes debridement devices, irrigation solutions, resorbable bead kits and wound gel.

Eric A. Stookey became Chief Executive Officer on July 1, 2026, following service as Chief Operating Officer.

^[1][19][20]

Products & regulatory status How does MedTechIndex get this information?

Summary

OsteoRemedies focuses on prosthetic joint infection and revision surgery. Its REMEDY spacer systems are temporary implants used between stages of revision, rather than permanent joint replacements. ^[3][4][1]

FDA records identify multiple 510(k) decisions across the hip, knee, shoulder and antibiotic-cement families. The current catalog also offers debridement, irrigation, resorbable bead and wound-care products. ^{[1][8][17][12][15][9][14][18][10][7][13][16][11]}

Regulatory snapshot How to read this snapshot

U.S. FDA

12+

510(k) clearances

—

De Novo grants

—

PMA approvals

—

Recall events

Latest recorded source review: 2026-10-31.

Scope: selected product families.

Commercial portfolio snapshot

Documented commercial product families.

Hip revision and infection management

REMEDY Hip Spacer family ↗

Modular, antibiotic-containing temporary hip spacers used during two-stage revision of an infected hip prosthesis. The standard REMEDY Hip Spacer is intended for temporary use of 180 days or less before removal and definitive reconstruction. The broader hip portfolio includes acetabular components and SPECTRUM GV and POLY+PLUS configurations. ^{[3][1][8][17][12][9][18][11]}

Marketed

Knee revision and infection management

REMEDY Knee and Stemmed Knee Spacer family ↗

Preformed knee spacer systems for staged revision procedures. The stemmed family includes all-poly tibial and POLY+PLUS configurations; components and trial instruments support surgeon sizing and assembly. ^{[6][1][15][10][13]}

Marketed

Shoulder revision and infection management

REMEDY Shoulder Spacer ↗

Antibiotic-containing temporary shoulder spacer for the interval between stages of infected joint replacement revision. The manufacturer specifies temporary use of 180 days or less, followed by removal and replacement with a permanent implant. ^[4][7]

Marketed

Antibiotic bone cement

SPECTRUM GV Bone Cement ↗

Bone cement containing gentamicin and vancomycin within the company’s orthopedic infection-management portfolio. ^[5][14][16]

Marketed